ECOSPOR III data

Time: 2:55 pm
day: Day 2 - Track B Evening

Details:

To highlight:

  • The efficacy and safety of SER-109 in patients with recurrent CDI
  • Efficacy of SER-109 versus placebo in patients with risk factors for recurrence
  • The time to recurrence and the importance of rapid microbiome recovery
  • Quality of life in patients receiving SER-109 compared to placebo
  • Inactivation of potential pathogens in donor stool via the manufacturing process

Speakers: